VIRI - Virios Therapeutics Inc. (VIRI) CEO Greg Duncan on Q1 2021 Results - Earnings Call Transcript
Virios Therapeutics, Inc. (VIRI) Q1 2021 Earnings Conference Call May 13, 2021 08:30 a.m. ET Company Representatives Greg Duncan - Chief Executive Officer Michael Gendreau - Chief Medical Officer Angela Walsh - Senior Vice President of Finance and Treasurer Ralph Grosswald - Vice President of Operations Conference Call Participants Presentation Operator Good morning, and welcome to Virios Therapeutics First Quarter 2021 Financial Results Conference Call. Please be advised that today’s call is being recorded at the company's request. At this time I'd like to turn the call over to Angela Walsh, SVP Finance and Treasurer of Virios Therapeutics; please proceed Angela. Angela Walsh Thank you. Good morning everyone and thank you for joining us on today's conference call. We are pleased to be with you today to discuss Virios Therapeutics, first quarter financial results, as well as to provide you with an update on the operational progress we have made
For further details see:
Virios Therapeutics, Inc. (VIRI) CEO Greg Duncan on Q1 2021 Results - Earnings Call Transcript